Magazine Article | June 1, 2022

How To Build A Strong CRO Partnership And Find Drug Development Success

Source: Life Science Leader

By Sabrina Johnson

When the WHO declared COVID-19 a pandemic, the world shut down. It was an unforgettable time in history: countries sealing borders, businesses closing, and governments issuing stay-at-home orders. Biotech and pharmaceutical companies around the globe fought to keep their clinical trials on track. But with altered clinic procedures, packed hospitals, masking, social distancing, and constantly evolving guidelines, we all felt the impact across clinical site engagement, study design, and patient enrollment. Effectively engaging with a CRO assisting with study execution had never been more important than in that moment — and during the two years that have passed since the WHO’s initial declaration of the pandemic.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader